Literature DB >> 25641525

Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy.

Doris G Leung1,2, John A Carrino3,4, Kathryn R Wagner1,2,5, Michael A Jacobs3,6.   

Abstract

INTRODUCTION: Facioscapulohumeral muscular dystrophy (FSHD) is a hereditary disorder that causes progressive muscle wasting. Increasing knowledge of the pathophysiology of FSHD has stimulated interest in developing biomarkers of disease severity.
METHODS: Two groups of MRI scans were analyzed: whole-body scans from 13 subjects with FSHD; and upper and lower extremity scans from 34 subjects with FSHD who participated in the MYO-029 clinical trial. Muscles were scored for fat infiltration and edema-like changes. Fat infiltration scores were compared with muscle strength and function.
RESULTS: The analysis revealed a distinctive pattern of both frequent muscle involvement and frequent sparing in FSHD. Averaged fat infiltration scores for muscle groups in the legs correlated with quantitative muscle strength and 10-meter walk times.
CONCLUSIONS: Advances in MRI technology allow for acquisition of rapid, high-quality, whole-body imaging in diffuse muscle disease. This technique offers a promising disease biomarker in FSHD and other muscle diseases.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  FSHD; MRI; facioscapulohumeral muscular dystrophy; radiographic biomarkers; whole-body imaging

Mesh:

Year:  2015        PMID: 25641525      PMCID: PMC4504833          DOI: 10.1002/mus.24569

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.852


  37 in total

1.  T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments.

Authors:  Hee Kyung Kim; Tal Laor; Paul S Horn; Judy M Racadio; Brenda Wong; Bernard J Dardzinski
Journal:  Radiology       Date:  2010-06       Impact factor: 11.105

2.  Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI.

Authors:  David B Olsen; Peter Gideon; Tina Dysgaard Jeppesen; John Vissing
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

3.  Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.

Authors:  Hermien E Kan; Tom W J Scheenen; Marielle Wohlgemuth; Dennis W J Klomp; Ivonne van Loosbroek-Wagenmans; George W Padberg; Arend Heerschap
Journal:  Neuromuscul Disord       Date:  2009-03-28       Impact factor: 4.296

4.  A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. The FSH-DY Group.

Authors: 
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

5.  Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group.

Authors:  K E Personius; S Pandya; W M King; R Tawil; M P McDermott
Journal:  Phys Ther       Date:  1994-03

6.  Health care utilization and expenditures for children and young adults with muscular dystrophy in a privately insured population.

Authors:  Lijing Ouyang; Scott D Grosse; Aileen Kenneson
Journal:  J Child Neurol       Date:  2008-04-10       Impact factor: 1.987

7.  Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression.

Authors:  R J Willcocks; I A Arpan; S C Forbes; D J Lott; C R Senesac; E Senesac; J Deol; W T Triplett; C Baligand; M J Daniels; H L Sweeney; G A Walter; K Vandenborne
Journal:  Neuromuscul Disord       Date:  2014-01-11       Impact factor: 4.296

Review 8.  Facioscapulohumeral muscular dystrophy.

Authors:  Rabi Tawil
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

9.  Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.

Authors:  K Kesper; C Kornblum; J Reimann; G Lutterbey; R Schröder; M P Wattjes
Journal:  Acta Neurol Scand       Date:  2008-12-22       Impact factor: 3.209

10.  Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th--13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June--1st July 2007, Naarden, The Netherlands; conjoint Institute of Myology TREAT-NMD meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France.

Authors:  E Mercuri; A Mayhew; F Muntoni; S Messina; V Straub; G J Van Ommen; T Voit; E Bertini; K Bushby
Journal:  Neuromuscul Disord       Date:  2008-09-24       Impact factor: 4.296

View more
  18 in total

Review 1.  Advanced MRI Techniques for Muscle Imaging.

Authors:  Vivek Kalia; Doris G Leung; Darryl B Sneag; Filippo Del Grande; John A Carrino
Journal:  Semin Musculoskelet Radiol       Date:  2017-08-03       Impact factor: 1.777

Review 2.  Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.

Authors:  Doris G Leung
Journal:  J Neurol       Date:  2016-11-25       Impact factor: 4.849

3.  MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.

Authors:  Grete Andersen; Julia R Dahlqvist; Christoffer R Vissing; Karen Heje; Carsten Thomsen; John Vissing
Journal:  J Neurol       Date:  2016-12-20       Impact factor: 4.849

Review 4.  Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2019-05-14       Impact factor: 3.217

5.  Adding quantitative muscle MRI to the FSHD clinical trial toolbox.

Authors:  Karlien Mul; Sanne C C Vincenten; Nicol C Voermans; Richard J L F Lemmers; Patrick J van der Vliet; Silvère M van der Maarel; George W Padberg; Corinne G C Horlings; Baziel G M van Engelen
Journal:  Neurology       Date:  2017-10-13       Impact factor: 9.910

6.  It's not all about muscle: fibroadipogenic progenitors contribute to facioscapulohumeral muscular dystrophy.

Authors:  Carlo Serra; Kathryn R Wagner
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

7.  Magnetic resonance imaging in facioscapulohumeral muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2018-01-23       Impact factor: 3.217

Review 8.  MR imaging of inherited myopathies: a review and proposal of imaging algorithms.

Authors:  Laís Uyeda Aivazoglou; Julio Brandão Guimarães; Thomas M Link; Maria Alice Freitas Costa; Fabiano Nassar Cardoso; Bruno de Mattos Lombardi Badia; Igor Braga Farias; Wladimir Bocca Vieira de Rezende Pinto; Paulo Victor Sgobbi de Souza; Acary Souza Bulle Oliveira; Alzira Alves de Siqueira Carvalho; André Yui Aihara; Artur da Rocha Corrêa Fernandes
Journal:  Eur Radiol       Date:  2021-04-21       Impact factor: 5.315

9.  Electrical impedance myography in facioscapulohumeral muscular dystrophy: A 1-year follow-up study.

Authors:  Karlien Mul; Chad Heatwole; Katy Eichinger; Nuran Dilek; William B Martens; Baziel G M Van Engelen; Rabi Tawil; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2018-04-17       Impact factor: 3.217

10.  Muscle MRI in muscular dystrophies.

Authors:  Jordi Díaz-Manera; Jaume Llauger; Eduard Gallardo; Isabel Illa
Journal:  Acta Myol       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.